Alzheimer's disease (AD) is a fatal neurodegenerative disorder characterised by progressive neuronal loss and cognitive decline. The lack of reliable and objective diagnostic markers for AD hampers early disease detection and treatment. Growing evidence supports the existence of a dysregulation in brain copper trafficking in AD. The 
INTRODUCTION
Alzheimer's disease (AD) is the most common form of dementia in the elderly. Its prevalence in an ageing global population is rapidly increasing, creating a major socioeconomic burden. There is no satisfactory method for its early diagnosis and no effective treatment to halt or delay the cognitive decline experienced by patients.
Currently, the most promising application of molecular imaging in AD is the visualisation of amyloid-β (Aβ) burden using positron emission tomography (PET) radioligands that bind specifically to Aβ plaques, such as the In recent years, there has been growing evidence associating changes in trafficking and distribution of trace metals, including copper, with the onset and progression of AD (5, 6) . Whether this association is a cause or consequence of the pathology is unknown and the nature of the changes is poorly understood. Copper has been found to interact with key components of AD pathology (Aβ, amyloid precursor protein [APP], β-secretase 1, tau) and, as a result, is thought to contribute to amyloidosis, synaptic toxicity and oxidative stress (7) (8) (9) (10) (11) . A plaques have been described as "sinks" of iron, zinc and copper ions (12, 13) , which have been shown to enhance Aβ aggregation and by on October 14, 2017 . For personal use only. jnm.snmjournals.org Downloaded from neurotoxicity (14, 15) . It has been suggested that the association of copper with Aβ aggregates and other molecular features of AD might also lead to decreased intracellular copper bioavailability and reduced activity of copper-dependent enzymes in the brain (16, 17) .
This "metal hypothesis of AD" is the basis of the development of treatments aimed at minimizing copper-induced neurotoxicity and restoring brain copper homeostasis (18).
Preclinical and clinical studies demonstrated reduced Aβ burden, increased intracellular copper levels and improved cognitive function following administration of copper (II) chelators (e.g. Clioquinol, PBT2) capable of stripping copper ions from Aβ plaque and redistributing them into cells (19) (20) (21) . A recent investigation showed that treatment with glyoxalbis(N 4 -methyl-3-thiosemicarbazonato) copper(II) (Cu-GTSM) -a copper bis(thiosemicarbazone) complex that delivers copper into cells and releases it bioreductively (22) -enhanced cognitive performance in APP/PS1 transgenic AD mice by triggering neuroprotective mechanisms that inhibited GSK3β and decreased phosphorylated tau and Aβ trimer levels (23) . Hence, understanding the role of copper homeostasis in AD pathology may be critical to development of both novel diagnostics and therapeutics.
A PET radiotracer able to measure brain copper trafficking in vivo could be a valuable tool to investigate changes in copper metabolism in brain, to determine the potential of copper dyshomeostasis as an early diagnostic marker for AD and as a useful complement to other imaging biomarkers. Positron-emitting copper isotopes ( Cu) can in principle be used to study the trafficking of copper to, from and within brain, not only in animal models but also in humans, by PET imaging over a period of hours and repeatedly during the lifetime of the subject. Intravenous injection of 64 Cu in the form of ionic copper (II) salts leads to delivery of radiotracer to the brain via native copper transport processes in quantities that are insufficient for meaningful imaging (24, 25) . However, by exploiting the ability of uncharged lipophilic copper(II) complexes, such as Cu-GTSM, to penetrate the blood-brain barrier (BBB) and release their copper payload non-selectively into cells (26) , the intracellular copper pool can be supplemented with tracer quantities of 64 Cu sufficient to allow imaging of its subsequent trafficking. A preliminary study by Fodero-Tavoletti and co-workers showed that 60 min after 64 Cu-labeled Cu-GTSM was administered intravenously, brain uptake of 64 Cu as measured by ex vivo gamma-counting was significantly greater in APP/PS1 mice than in their age-matched wild-type counterparts (27) . Following up on this work, in the present study we explore further the trafficking of copper in AD by PET imaging with 64 Cu-GTSM in the APPswe x PS1.M146V (TASTPM) transgenic mouse model. TASTPM mice rapidly develop some of the key pathological features of AD, such as cerebral Aβ plaque deposition, neuronal loss and neuroinflammation, showing impaired cognitive function at 6 months of age (28, 29) . The visualization, mapping and monitoring of 64 Cu trafficking in this model of AD will provide valuable information to determine the potential of imaging brain copper trafficking as a diagnostic marker for AD. 
MATERIALS AND METHODS

RESULTS
Solvent extraction
To assess the ability of 64 Cu-GTSM to release 64 Cu intracellularly within the brain, we determined the amount of intact complex in brain homogenates of mice injected with 64 Cu-GTSM using a previously reported octanol-extraction method (36) . Almost all 64 Cu partitioned in the aqueous/protein-bound in both TASTPM mice and age-matched controls; 3.81 ± 2.98 % of brain 64 Cu radioactivity was associated with the octanol fraction at 30 min and 2.82 ± 0.14 % at 24 h after injection. Radio-TLC showed that even the octanol-extractable fraction contained no intact 64 Cu-GTSM.
PET imaging
Whole-body copper fluxes in vivo in TASTPM mice (n = 4) were imaged with 64 Cu-GTSM from 0-30 min and from 24-25 h after injection and compared to wild-type controls (n = 6). The general biodistribution of the tracer was similar for both animal by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from 8 groups ( Fig. 1) . At 30 min, 64 Cu radioactivity accumulated primarily in the heart, lungs, liver, intestines, kidneys, spinal cord and brain in both TASTPM and wild-type mice.
After 24 h, a notable decrease in 64 Cu activity was observed in the lungs, kidneys and heart, whereas 64 Cu concentration in the brain declined much less (supplemental, Fig.   S1 ). 64 Cu biokinetics within the central nervous system (CNS: brain and spinal cord) were compared in AD mice and healthy controls using PET ROI analysis (see Fig. 2 and Fig.   S2 ). PET quantification revealed that global average brain concentration of 64 Cu was significantly higher in TASTPM transgenic mice than in wild-type controls at 30 min (7.83 ± 1.08 %ID/g vs. 5.57 ± 0.70 %ID/g, p<0.01) and 24 h (7.04 ± 0.94 %ID/g vs. 5.46 ± 0.70 %ID/g, p<0.05). After 24 h, a significant decrease in brain 64 Cu concentration was found in TASTPM mice (-10.10 ± 2.23 %, p<0.01) but not in age-matched controls (-2.04 ± 3.57 %, p>0.05). TASTPM mice also exhibited significantly higher Atlas-based image analysis of regional brain concentration of 64 
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As depicted in Fig.3 (see also supplementary information, Fig. S3 ), 64 Cu-GTSM distribution in the brains of both wild-type and TASTPM mice was heterogeneous both at 30 min and 24 h. To quantify heterogeneity in a functional/anatomical context, brain PET images were analyzed using a 3D mouse brain atlas (Fig. 4) . TASTPM mice showed higher 64 Cu concentration than controls in all defined regions, reaching Table S1 ).
Texture analysis
Statistical data emerging from texture analysis are listed in supplementary data (Table   S2 ). The TASTPM group showed increased standard deviation (p<0.05) and coefficient of variation (p<0.01) compared to controls, demonstrating a higher spread and nonuniformity in voxel intensity values. TASTPM brain images had also higher entropy (p<0.01) than those of wild-type mice, revealing an increased level of disorder in voxel intensity distribution. The energy of TASTPM brain images was lower (p<0.05) compared to that of control datasets, suggesting a broader histogram and spread of voxel intensity values. The TASTPM group also showed a lower kurtosis (p<0.01) than controls, which is indicative of a voxel intensity distribution less clustered around the mean and more spread, compared to the control group. Skewness was more negative (p<0.01) for controls than for TASTPM mice, indicating a greater spread for voxel intensity values lower than the median than for those higher than the median in wildtype datasets. All measures of central tendency of the datasets (mean, median, maximum, minimum, range and percentiles) were higher for the TASTPM group than for wild-type mice, which is indicative of increased tracer uptake in the brains of TASTPM mice compared to controls.
Ex vivo biodistribution
Following PET imaging, the ex vivo biodistribution of 64 Cu at 24 h post-injection of 64 Cu-GTSM was evaluated by gamma-counting of explanted organs (Fig. 5) . Only lung tracer uptake was found to differ significantly between groups and was higher in TASTPM than controls (21.30 ± 5.39 %ID/g vs. 17.54 ± 1.22 %ID/g, p<0.05). Global brain uptake was consistently raised in TASTPM mice compared to age-matched controls, but by the tests employed the difference was not significant (p>0.05). The brain %ID/g values determined by ex vivo organ counting showed a moderately strong correlation (r 2 = 0.61) with whole-brain uptake measured by PET (see supplementary data, Fig. S4 ).
Ex vivo brain autoradiography
To evaluate further the heterogeneity in the brain distribution of 64 Cu, sagittal brain slices of TASTPM (n = 4) and control mice (n = 6) sacrificed 24 h after 64 Cu-GTSM injection were imaged using phosphor imaging autoradiography. Ex vivo autoradiographs (Fig. 6 ) confirmed heterogeneous 64 Cu uptake within brain tissue and the localization of radioactive hotspots in the medulla, cerebellum, pons, midbrain, caudate putamen and olfactory bulb seen by PET imaging. Visual inspection of representative digital autoradiographs showed increased tracer uptake and greater heterogeneity in 64 Cu brain distribution in TASTPM mice compared to controls.
Histology
by on October 14, 2017. For personal use only. jnm.snmjournals.
org Downloaded from
To determine whether the regional brain distribution of 64 Cu was related to Aβ plaque deposition, TASTPM brain slices were autoradiographed and subsequently stained with Congo red (Fig. 7) . Although 64 Cu was taken up by the entire brain, the areas with the most prominent radioactive hotspots (olfactory bulb, medulla, cerebellum, midbrain, pons and caudate putamen) did not correspond to the regions with highest Aβ plaque load (hippocampus, thalamus and cerebral cortex).
DISCUSSION
In this study, we aimed to explore brain copper trafficking in TASTPM mice and agematched controls at the earliest stage at which cognitive impairment can be detected in this transgenic model (i.e. 6 months old) (28) , by PET imaging using 64 Cu-GTSM. The chosen route of administration of 64 Cu-GTSM was intravenous injection, which does not mimic the gastrointestinal uptake and biodistribution of endogenous copper but ensures rapid delivery of the radiotracer into the brain. To confirm the ability of the tracer to release radiocopper intracellularly within the brain, we used solvent extraction to measure the amount of intact (octanol-soluble) 64 Cu-GTSM present in brain homogenates, at different time-points after injection. The low 64 Cu present in the octanol-extractable fraction, and the lack of 64 Cu-GTSM complex detectable by radio-TLC of that fraction, indicated that 64 Cu-GTSM was almost completely dissociated by 30 min. Combined with the PET imaging studies which showed remarkably high and rapid 64 Cu-GTSM uptake in the brain, this is consistent with a process in which the lipophilicity of the 64 Cu-GTSM complex facilitates its passage across the BBB and into cells where it dissociates, releasing 64 Cu intracellularly, as previously suggested for this family of by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from compounds (22, 26, 37, 38) . The speciation of the dissociated 64 Cu in the intracellular copper pool remains unknown. 64 Cu-GTSM PET imaging also indicated that clearance of radiocopper from the brain is considerably slower than from most other tissues (e.g. heart, kidneys, lungs), for reasons not yet clear; it may be that brain tissue has greater active sequestration of copper ions driven by increased metabolic needs associated with regular brain function, or less active efflux mechanisms.
PET imaging of copper trafficking with 64 Cu-GTSM revealed significantly increased brain and spinal cord uptake of 64 Cu in TASTPM mice at 30 min and 24 h, compared to healthy controls. Despite differences in the animal model, age range and methods used, these results agree with those reported by Fodero-Tavoletti et al. (27) , who reported Cu clearance from brain was slower than that from other tissues in both TASTPM and wild-type mice, washout between 30 min and 24 h was significantly faster, by a factor of 5, in TASTPM mice than in healthy controls (-10 % vs. -2 %).
by
Nevertheless, TASTPM mice still had significantly higher 64 Cu concentration in brain than controls both at 30 min and 24 h. These differences in brain copper trafficking between the two groups may be due to more active copper influx and efflux mechanisms in the TASTPM model, or different patterns of copper bioavailability to these processes. The molecular mechanisms underlying the increased uptake in TASTPM brains have yet to be elucidated; it may be driven by the regulation of total brain copper levels in an effort to maintain brain copper homeostasis and/or enhance copper-dependent antioxidant enzyme activity as a response to oxidative stress. On the other hand, faster brain clearance of 64 Cu in TASTPM transgenic mice may be caused by the overexpression of APP, for which a role in normal copper metabolism as an efflux transporter has been suggested (11).
Both PET and ex vivo autoradiography demonstrated that accumulation of 64 Cu within the brain at 30 min and 24 h was heterogeneous. Seeking to rationalize 64 Cu this heterogeneity, we measured 64 Cu brain regional uptake using a 3D mouse brain atlas and found it to be higher in all brain regions in TASTPM mice compared to controls, with differences between the two groups reaching statistical significance in specific areas at 30 min and 24 h post-injection of the tracer. It should be noted that many of these brain regions are very small compared to the limited spatial resolution of the PET/CT scanner.
The heterogeneity in 64 Cu concentration will therefore inevitably have been underestimated by atlas-based quantification due to the partial volume effect; combined with the lack of flexibility of segmentation boundaries and the potential for imperfect by on October 14, 2017. For personal use only. jnm.snmjournals.org Downloaded from matching of atlas regions onto real brain images, these results must be interpreted cautiously.
To avoid subjectivity in interpreting regional variations in brain uptake of 64 Cu because of these limitations, PET brain signal heterogeneity was alternatively measured by texture analysis, which interrogates global and regional patterns of image heterogeneity without an underlying biological or structural model. Statistical analysis of first-order texture parameters revealed a higher spread, asymmetry and non-uniformity of the voxel intensity distribution in TASTPM brain images, indicating a greater degree of image heterogeneity in the disease model compared to controls. While this does not offer a biological interpretation of differences in brain uptake of 64 Cu between the two animal groups, it does offer a basis for parameterisation of imaging for clinical diagnostic purposes.
The sequestration of copper by extracellular Aβ plaque deposits is thought to contribute to brain copper dyshomeostasis in AD by reducing the intracellular bioavailability of copper ions (6, 12, 13, 39, 40) . To determine the extent of correlation between the regional distribution of and 24 h (bottom). Statistically significant differences are indicated by * (p<0.05), ** (p<0.01) and *** (p<0.001). Data are mean (n = 4 for TASTPM mice; n = 6 for controls) ± SD.
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